Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood.
Demi BrownlieMarlena ScharenbergJeff E MoldJoanna HårdEliisa KekäläinenMarcus BuggertSon NguyenJennifer N WilsonMamdoh Al-AmeriHans-Gustaf LjunggrenNicole MarquardtJakob MichaëlssonPublished in: Proceedings of the National Academy of Sciences of the United States of America (2021)
Human adaptive-like "memory" CD56dimCD16+ natural killer (NK) cells in peripheral blood from cytomegalovirus-seropositive individuals have been extensively investigated in recent years and are currently explored as a treatment strategy for hematological cancers. However, treatment of solid tumors remains limited due to insufficient NK cell tumor infiltration, and it is unknown whether large expansions of adaptive-like NK cells that are equipped for tissue residency and tumor homing exist in peripheral tissues. Here, we show that human lung and blood contains adaptive-like CD56brightCD16- NK cells with hallmarks of tissue residency, including expression of CD49a. Expansions of adaptive-like lung tissue-resident NK (trNK) cells were found to be present independently of adaptive-like CD56dimCD16+ NK cells and to be hyperresponsive toward target cells. Together, our data demonstrate that phenotypically, functionally, and developmentally distinct subsets of adaptive-like NK cells exist in human lung and blood. Given their tissue-related character and hyperresponsiveness, human lung adaptive-like trNK cells might represent a suitable alternative for therapies targeting solid tumors.
Keyphrases
- nk cells
- induced apoptosis
- peripheral blood
- cell cycle arrest
- endothelial cells
- gene expression
- endoplasmic reticulum stress
- machine learning
- healthcare
- cell death
- poor prognosis
- patient safety
- drug delivery
- epstein barr virus
- quality improvement
- artificial intelligence
- mass spectrometry
- deep learning
- cancer therapy
- combination therapy
- atomic force microscopy